Annual Drug Patent Expirations for BIJUVA
Bijuva is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are nineteen patents protecting this drug.
Drug patent litigation for BIJUVA.
This drug has one hundred and thirty-eight patent family members in nineteen countries.
The generic ingredient in BIJUVA is estradiol; progesterone. One supplier is listed for this compound. Additional details are available on the estradiol; progesterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
